SCHEMBL25005396

SCHEMBL25005396

CCC(=O)N1CCc2cccc(Nc3nc(Cl)ncc3Cl)c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 3/20 0.44
ALK Q9UM73 5/20 0.42
MET P08581 2/20 0.42
EGFR P00533 3/20 0.41
NOTUM Q6P988 1/20 0.41
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 2/20 0.39
INSR P06213 2/20 0.39
FGFR1 P11362 1/20 0.39
SRC P12931 1/20 0.39
MAP2K1 Q02750 1/20 0.39
SLC2A1 P11166 1/20 0.38
MAP4K1 Q92918 1/20 0.38
MAPK8 P45983 1/20 0.38
CCNK O75909 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CCND3 P30281 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25005397 0.94 MAP3K7 (0.43) MAP3K7ALKMETEGFRMAPK1
SCHEMBL25004485 0.89 NOTUM (0.55) MAP3K7ALKMETEGFRNOTUM
SCHEMBL30425571 0.83 CCNK (0.49) MAP3K7ALKMETEGFRNOTUM
SCHEMBL26655582 0.83 CCNK (0.49) MAP3K7ALKMETEGFRNOTUM
SCHEMBL25005398 0.82 NOTUM (0.47) MAP3K7ALKMETEGFRNOTUM
SCHEMBL25014390 0.80 CDK9 (0.40) MAP3K7ALKEGFRMAP4K1CCNK
SCHEMBL30942601 0.80 CCNK (0.41) MAP3K7ALKEGFRMAPK1FGFR1
SCHEMBL25014389 0.79 CCNA2 (0.39) MAP3K7ALKMAP4K1CCNKCCNA2
SCHEMBL31147629 0.78 NOTUM (0.50) ALKNOTUM
SCHEMBL27237971 0.78 NOTUM (0.50) ALKNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382514-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2024-06-12 EP disclosed
CN-117794914-A Pyrimidine-2, 4-diamine derivatives, process for preparing the same, and pharmaceutical composition for preventing or treating cancer comprising the same as active ingredient 韩国化学研究院 2024-03-29 CN disclosed
WO-2023014022-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 한국화학연구원 2023-02-09 WO disclosed
WO-2023287130-A1 NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 한국화학연구원 2023-01-19 WO disclosed